## Abstract The reputation of RUNX3 as a strong candidate for a tumor suppressor originated from studies of gastric carcinogenesis and now extends to a variety of other human cancers. The RUNX3 transcription factor is a downstream effector of the TGFโฮฒ superfamily signaling pathway and has a critic
Oncogenic role of RUNX3 in head and neck cancer
โ Scribed by Dr. Yasusei Kudo; Takaaki Tsunematsu; Takashi Takata
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 236 KB
- Volume
- 112
- Category
- Article
- ISSN
- 0730-2312
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
Cumulative evidences show that Runtโrelated transcription factor 3 (RUNX3) has a tumor suppressive role in various cancers. In particular, RUNX3 appears to be an important component of the transforming growth factorโฮฒ (TGFโฮฒ)โinduced tumor suppression pathway. Contrary to reports on this tumor suppressive role of RUNX3, RUNX3 can also function as an oncogene when overexpressed. Recently, we found that RUNX3 overexpression was frequently observed and was well correlated with malignant behaviors in head and neck cancer, which is one of the most common types of human cancer. Moreover, it has been revealed that RUNX3 overexpression promoted cell growth and inhibited apoptosis in head and neck cancer cells. This review introduces the oncogenic role of RUNX3 in certain types of cancer including head and neck cancer. J. Cell. Biochem. 112: 387โ393, 2011. ยฉ 2010 WileyโLiss, Inc.
๐ SIMILAR VOLUMES
Cancer of the head and neck arises most often from body surfaces that have been exposed to deleterious environmental influences. These body surfaces include the skin and the linings of the air and food passages. Solar radiation, alcohol, and tobacco are currently at the top of the list of the damagi
## Abstract Head and neck cancer is the world's sixth most common cancer, but despite advances in treatment, there has been no significant decline in the mortality rate. In recent years, there has been mounting epidemiologic and experimental evidence of a role for human papillomavirus (HPV) as the
Brachytherapy offers the radiation oncologist the opportunity to deliver high doses of radiation to the tumor, with minimal doses to the surrounding normal tissue. This combination enhances the therapeutic ratio. It allows for enhanced tumor control, with minimal toxicity. When utilized, it often al